Insider Selling: HealthEquity, Inc. (HQY) Director Sells 131,800 Shares of Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Frank Medici sold 131,800 shares of the company’s stock in a transaction on Thursday, July 13th. The stock was sold at an average price of $51.42, for a total value of $6,777,156.00. Following the transaction, the director now owns 6,381 shares of the company’s stock, valued at $328,111.02. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Frank Medici also recently made the following trade(s):

  • On Wednesday, July 12th, Frank Medici sold 332,511 shares of HealthEquity stock. The shares were sold at an average price of $51.13, for a total value of $17,001,287.43.
  • On Friday, July 14th, Frank Medici sold 537,102 shares of HealthEquity stock. The shares were sold at an average price of $51.24, for a total value of $27,521,106.48.
  • On Friday, July 7th, Frank Medici sold 186,749 shares of HealthEquity stock. The shares were sold at an average price of $50.26, for a total value of $9,386,004.74.
  • On Wednesday, July 5th, Frank Medici sold 23,649 shares of HealthEquity stock. The shares were sold at an average price of $50.27, for a total value of $1,188,835.23.
  • On Wednesday, June 21st, Frank Medici sold 154,265 shares of HealthEquity stock. The shares were sold at an average price of $51.94, for a total value of $8,012,524.10.
  • On Wednesday, June 14th, Frank Medici sold 210,906 shares of HealthEquity stock. The stock was sold at an average price of $52.03, for a total value of $10,973,439.18.

HealthEquity, Inc. (NASDAQ HQY) traded down 4.54% during mid-day trading on Friday, reaching $42.08. The company’s stock had a trading volume of 1,305,719 shares. The stock has a market cap of $2.52 billion, a PE ratio of 79.10 and a beta of 1.73. The company has a 50 day moving average of $48.13 and a 200-day moving average of $46.07. HealthEquity, Inc. has a 52-week low of $28.39 and a 52-week high of $54.95.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.03. The company had revenue of $55.40 million for the quarter, compared to analysts’ expectations of $54.77 million. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. HealthEquity’s revenue was up 25.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.15 EPS. Equities analysts forecast that HealthEquity, Inc. will post $0.58 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Insider Selling: HealthEquity, Inc. (HQY) Director Sells 131,800 Shares of Stock” was first published by BNB Daily and is the sole property of of BNB Daily. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.baseball-news-blog.com/2017/08/19/insider-selling-healthequity-inc-hqy-director-sells-6777156-00-in-stock-updated-updated-updated.html.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Fifth Third Bancorp raised its position in HealthEquity by 382.8% in the first quarter. Fifth Third Bancorp now owns 2,414 shares of the company’s stock worth $102,000 after buying an additional 1,914 shares during the period. Oppenheimer Asset Management Inc. bought a new position in shares of HealthEquity during the first quarter valued at about $106,000. Arcadia Investment Management Corp MI raised its position in shares of HealthEquity by 81.7% in the first quarter. Arcadia Investment Management Corp MI now owns 2,515 shares of the company’s stock valued at $107,000 after buying an additional 1,131 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of HealthEquity by 105.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock valued at $127,000 after buying an additional 1,308 shares during the period. Finally, Riverhead Capital Management LLC raised its position in shares of HealthEquity by 75.3% in the second quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock valued at $131,000 after buying an additional 1,129 shares during the period. Institutional investors and hedge funds own 90.54% of the company’s stock.

Several brokerages recently issued reports on HQY. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $61.00 price objective (up from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research note on Wednesday, July 12th. Cantor Fitzgerald raised their price target on HealthEquity from $55.00 to $56.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 5th. BidaskClub downgraded HealthEquity from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Finally, Chardan Capital raised their price target on HealthEquity from $53.00 to $57.00 and gave the stock a “buy” rating in a research note on Wednesday, June 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $50.22.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply